In his presentation 'How to use CRISPR-Cas to combat AMR' at the ESCMID Global Congress, Assistant Prof.
CRISPR is promising to tackle antimicrobial resistance, but bacteria can fight back retrieved 26 April 2024 from https://phys.org/news/2024-04-crispr-tackle-antimicrobial-resistance-bacteria.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.Get weekly and/or daily updates delivered to your inbox.
Physics News Science News Technology News Physics Materials Nanotech Technology Science
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AMR employee from El Cajon honored for 55 years of public serviceAmerican Medical Response hosted a special event Friday for its longest-serving employee, El Cajon-native Gordon Anderson, who has been with the company for 55…
Read more »
AMR offering free EMT training academy for womenFree training academy offered at Miramar College this fall.
Read more »
New CRISPR tool orchestrates antiviral defense within cellsThe rise of RNA viruses like SARS-CoV-2 highlights the need for new ways to fight them. RNA-targeting tools like CRISPR/Cas13 are powerful but inefficient in the cytoplasm of cells, where many RNA viruses replicate.
Read more »
Researchers systematically investigate efficacy of CRISPR antimicrobial agentsThe antimicrobial potential of CRISPR-Cas systems is promising, yet how to best design or implement CRISPR nucleases remains poorly understood. An international team led by the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now addressed this knowledge gap.
Read more »
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plantsScientists at the Leibniz Institute of Plant Biochemistry (IPB) have succeeded for the first time in stably and precisely inserting large gene segments into the DNA of higher plants very efficiently. To do this, they optimized the gene-editing method CRISPR/Cas, commonly known as 'genetic scissors.
Read more »
Swiss title challenger Servette loses appeal at CAS over failure to register 2 new playersSwiss soccer club Servette has lost an appeal at the Court of Arbitration for Sport over failing to register two players it signed in January to help challenge for the club's first league title in 25 years. Servette added Arsenal defender Omar Rekik and Lorient forward Bassirou N’Diaye on loan deals for the pursuit of defending champion Young Boys.
Read more »